-
13119-500A platinum-containing compound that acts as an alkylating agent used alone or in combination therapy in the treatment of several types of cancer inhibits the RecA recombinase of M. tuberculosis (IC<sub>50</sub> = 2 µM), blocking protein
-
14572-1A SSRI which is commonly prescribed as an antidepressant also acts as an antagonist of nicotinic acetylcholine receptors (IC<sub>50 </sub>= 0.93 µM).
-
14572-100A SSRI which is commonly prescribed as an antidepressant also acts as an antagonist of nicotinic acetylcholine receptors (IC<sub>50 </sub>= 0.93 µM).
-
14572-500A SSRI which is commonly prescribed as an antidepressant also acts as an antagonist of nicotinic acetylcholine receptors (IC<sub>50 </sub>= 0.93 µM).
-
16027-10An agonist of human CAR (EC<sub>50</sub> = 49 nM) induces nuclear translocation of human CAR in hepatocytes, followed by increased expression of CAR-regulated genes.
-
16027-25An agonist of human CAR (EC<sub>50</sub> = 49 nM) induces nuclear translocation of human CAR in hepatocytes, followed by increased expression of CAR-regulated genes.
-
16027-5An agonist of human CAR (EC<sub>50</sub> = 49 nM) induces nuclear translocation of human CAR in hepatocytes, followed by increased expression of CAR-regulated genes.
-
14629-1An endogenous intermediate in the synthesis of phosphatidylcholine that demonstrates protective effects in cerebral ischemia, traumatic brain injury, and memory disorders when administered exogenously.
-
14629-100An endogenous intermediate in the synthesis of phosphatidylcholine that demonstrates protective effects in cerebral ischemia, traumatic brain injury, and memory disorders when administered exogenously.
-
14629-50An endogenous intermediate in the synthesis of phosphatidylcholine that demonstrates protective effects in cerebral ischemia, traumatic brain injury, and memory disorders when administered exogenously.
-
14629-500An endogenous intermediate in the synthesis of phosphatidylcholine that demonstrates protective effects in cerebral ischemia, traumatic brain injury, and memory disorders when administered exogenously.
-
11319-1A mycotoxin that inhibits the mitochondrial ATP synthetase system inhibits soluble ATPase (KD = 4.1 µM), ADP-stimulated respiration in isolated rat liver mitochondria (KD = 0.